NCH has become the first in the U.S. to perform a new catheter-based mitral valve replacement procedure, offering a less invasive option for high-risk heart patients. Using the FDA-approved SAPIEN M3 valve, NCH doctors replaced a failing mitral valve through a catheter inserted in the groin, avoiding open-heart surgery. The procedure provided a faster recovery for patient Bob Dickemper and represents a significant advancement in treatment options for complex heart conditions.
Read the full article → NCH performs groundbreaking mitral valve procedure